About General Prognostics
General Prognostics is a company based in Boston (United States) founded in 2020 by Javier Echenique, Sean Matsuoka, and Sidhant Jena.. General Prognostics has raised $3.25 million across 5 funding rounds from investors including UMass Lowell, NEC X and D4V. General Prognostics operates in a competitive market with competitors including iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others.
- Headquarter Boston, United States
- Founders Javier Echenique, Sean Matsuoka, Sidhant Jena
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.25 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
UMass Lowell
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of General Prognostics
General Prognostics has successfully raised a total of $3.25M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(29 Oct 2020)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Seed - General Prognostics | Valuation |
investors |
|
| Jun, 2024 | Amount | Debt – Conventional - General Prognostics | Valuation |
investors |
|
| Sep, 2022 | Amount | Seed - General Prognostics | Valuation | D4V |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in General Prognostics
General Prognostics has secured backing from 5 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include UMass Lowell, NEC X and D4V. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
NEC X is engaged in supporting early-stage tech startups.
|
Founded Year | Domain | Location | |
|
Venture capital firm focusing on Japanese startups
|
Founded Year | Domain | Location | |
|
Undergraduate and graduate education programs are provided across disciplines.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by General Prognostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - General Prognostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
General Prognostics Comparisons
Competitors of General Prognostics
General Prognostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, AliveCor, Biotricity, Cardiotrack and Element Science, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| domain | founded_year | HQ Location |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| domain | founded_year | HQ Location |
AI-based EGC data capture and analysis platform
|
|
| domain | founded_year | HQ Location |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| domain | founded_year | HQ Location |
Online health and wellness tracking and training platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on General Prognostics
Frequently Asked Questions about General Prognostics
When was General Prognostics founded?
General Prognostics was founded in 2020.
Where is General Prognostics located?
General Prognostics is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of General Prognostics?
Javier Echenique is the current CEO of General Prognostics. They have also founded this company.
Is General Prognostics a funded company?
General Prognostics is a funded company, having raised a total of $3.25M across 5 funding rounds to date. The company's 1st funding round was a Seed of $3.25M, raised on Oct 29, 2020.
What does General Prognostics do?
General Prognostics was founded in 2020 in Boston, United States, and operates in the healthcare sector. AI-driven tools for health monitoring are developed, focusing on biomarker-based remote solutions for cardio-renal diseases. Blood analysis and remote monitoring capabilities are included, along with presymptomatic detection of critical conditions in patients. Services target healthcare professionals for improved patient outcomes.
Who are the top competitors of General Prognostics?
General Prognostics's top competitors include AliveCor, iRhythm Tech and Biotricity.
Who are General Prognostics's investors?
General Prognostics has 5 investors. Key investors include UMass Lowell, NEC X, D4V, Pete Moran, and Hiroaki Kitano.